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When one considers the stresses to which we 
subject the weight-bearing joints of our body over 
the course of a lifetime, one begins to appreciate 
the remarkable dependability and durability of that 
very thin layer of articular cartilage which covers 
the surfaces of those joints. Imposed on these sur¬ 
faces are variety of constant and cyclic loads, stem¬ 
ming from forces which are both compressive and shear¬ 
ing. Yet, this thin layer stands up to year after 
year of load-bearing, with its own system of lubrica¬ 
tion and replenishment of worn meterial, an achievement 
which cannot be boasted by any man-made mechanical 
device. 
Unfortunately, nature Itself is not free 
from imperfections and this wondrous mechanical system 
often fails. A small mechanical breakdown, a slight 
biochemical change often leads to a chain of events 
which results in pain and incapacitation. It is esti¬ 
mated that some 40 million Americans manifest radio¬ 
logical evidence of such joint degeneration, including 
some 85# of all those over 70 years of age and at a 
cost of $13 billion in 1976. 
This paper will briefly discuss some of the 
pertinent properties of articular cartilage and degen¬ 
erative joint disease (osteoarthritis). It will then 
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turn to some of the current ideas concerning the bio¬ 
chemical processes which may be responsible for joint 
failure and some of the experiments performed here to 
help elucidate one of these ideasi that the joint 
disease is mediated through the production of prosta¬ 





Joint development begins during the fifth 
to sixth week of embryonic life with the appearance of 
limb buds (Langman 1975) • Soon thereafter, clefts 
appear in the appendages, forming joints. At birth, 
endochondral bone formation occurs at the epiphyses. 
The articular cartilage may be considered as a partial 
spherical shell which covers the cartilage surrounding 
the ossification center. This superficial shell has 
a separate population of chondrocytes which lay down the 
articular cartilage. It ceases to proliferate at about 
the first year of life (Mankin 1963). 
Upon skeletal maturity and the appearance 
of the tidemark (seen on hematoxylin-eosin staining), 
no further mitosis occurs (mankln 1963, Crelin 1957)* 
However, under appropriate stimulation, the chondro¬ 
cytes can revert to a chondroblastic form with DNA 
production, mitosis and increased mucopolysaccharide 
production. These stimuli may be growth hormone (Chris- 
man 1975). sustained compression (Crelin & Southwlck 
i960), laceration (Meachim 1963) and osteoarthritic 
destruction (McDevitt 1973)* Unfortunately, in the last 
case, the new proteoglycans are either not produced 
in sufficient quantities or are of poorer quality 




Besides the chondrocytes, articular cartilage 
consists mostly of matrix made up of 3 principal compo¬ 
nents! water, collagen and proteoglycans. 
Wateri Seventy five to 85$ of the weight of 
articular cartilage is comprised of water (Mankin & 
Thrasher 1975)* Of this, about is mechanically 
trapped in a complex gel of collagen and proteoglycan 
and is freely exchangeable with both the synovial fluid 
and systemic circulation (Jaffe, et al 197*+) • 
Collagen 1 Collagen fibrils are aggregates 
of tropocollagen molecules. Tropocullagen is usually 
a triple helix with 2 identical <x-j_ chains and a some¬ 
what differentcx2 chain (Muir 1873)* For example, 
skin collagen is a mixture of molecules of compositions 
(5*1 (1)] 2<*2 and [9^1 (111 3 (McDevltt 1973)* Articular 
cartilage tropocollagen consists of 3 identical strands 
of 04(11) chains, which has properties very similar to 
the 0(^(1) chain from skin (Strawich & Minimi 1971)* It 
should be noted that articular cartilage collagen is 
almost completely resistant to extraction by reagents 
commonly used for extraction of skin cartilage, such 
5 M guanidine-HCl (Miller, et al 1969), 2 M MgCl2 or 
6 M urea (Strawich & Nimmi 1971)• This has been attri¬ 
buted to both intra- and inter-molecular cross-linking 
and ionic interactions between the positively charged 
proteoglycans (McDevltt 1973)* 
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The biocynthesis of collagen Is now well- 
understood though the work has been done mostly with 
chick embryo cartilage (Muir 1973)* The polypeptide 
chains are formed singly which then spontaneously ag¬ 
gregate to form a triple helix, at which stage, the 
molecule is referred to as protocollagen. Hydroxylation 
of some of the proline and lysine residues then occurs 
(Rosenbloom & Prockop 1969)* A different enzyme is 
involved in the hydroxylation of each (Weinstein, et al 
1969)* Some of the hydroxylated lysine residues are 
then glycoslated to either glycosyl-galactosyl-hydroxy- 
lysine or galactosyl-hydroxylysine (31umenkrantz, et al 
1969)» before the tropocollagen molecule is secreted 
from the cell. In the cartilage matrix, the molecules 
aggregate to form fibrils, after which a slow matura- 
tional process of intra- and intermolecular cross- 
linking occurs (Muir 1973)* 
There is a slow, but detectable level of coll¬ 
agen turnover in adult rabbit articular cartilage which 
increases with experimentally-induced osteoarthritis 
(Repo & Mitchell 1971)• 
Proteoglycans 1 Proteoglycans are large mole¬ 
cules which structurally consist of a protein core from 
which are hung glycosaminoglycan side chains, made of 
3 major disaccharides 1 chondroitln-4-sulphate, chondroitin' 
6-sulphate and keratan sulfate, the structures of which 
are shown in Figure 1. Chondroitih-4-sulfate has a 

OH H NHAc 
Figure It Disaccharide repeating units of (a) chondroitin 
4-sulphate, (b) chondroitin 6-sulphate and 
(c) keratan sulphate. 
(From Freeman M.A.R. 1974) 
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disaccharide unit consisting of glucuronic acid linked 
to N-acetyl galactosamine, with the sulphate group at 
the galactose C4 position. In the case of chondroitin- 
6-sulphate, the sulphate is in the C6 position. In 
keratan sulphate, there is a galactose molecule linked 
to an N-acetyl glueosamine-6-sulphate molecule. The 
chondroitin sulphate chains tend to be linear, with 30 
to 60 disaccharide units, while that of keratan sulphate 
may be more variable, with 15 to 30 disaccharide units 
per chain with some branch points (Hopwocd & Robinson 
1974). Moreover, keratan sulphate also contains small 
amounts of other sugars such as fucose, sialate, galac¬ 
tosamine and mannose (Mathews & Cifonelli 1965)* The 
chondroitin sulphate chains do not appear to be distri¬ 
buted uniformly along the protein core but are present 
in pairs (Mathews 1971), with about 10 amino acid resi¬ 
dues between individual chains and about 35 residues 
between pairs. It is believed that the protein core 
helps to protect the polysaccharides from enzymatic 
attack by holding them closely together (Muir 1973)* 
This is consistent with the observation that proteo¬ 
glycans are more susceptible to attack by proteolytic 
ensymes than hyaluronidases (Cessi & Bernardi 1965) • 
The relative proportions of the glycosaminoglycans change 
over life. The concentration of keratan sulphate 
increases, that of chondroltin-4-sulphate falls and 
that of chondroitin-6-sulphate remains constant (Barnett, 

7 
et al 1963) • 
The proteoglycan monomer appears as a comb 
with the protein core acting as the "backbone" and the 
polysaccharide "teeth" hanging from it. Rosenberg has 
postulated that the C terminals of the polypeptides 
associate to form a dimer. Dimers then aggregate around 
a link protein to form starlike first-order aggregates. 
The free N terminals of some of the "arms" of the stars 
can further associate with link proteins of other first- 
order aggregates to form second order aggregates (clus¬ 
ters of stars) (Rosenberg, et al 1970), although it is 
unclear that this actually occurs in vivo. In addition 
to the link protein, hyaluronic acid is necessary for 
aggregation* and the present evidence suggests that it 
interacts directly with one part of the link protein 
(Hardingham & Muir 1972, 1973» Kuettner, et al 1975) • 
Several "stars" are believed to be strung out along a 
long strand of hyaluronic acid. This extended structure 
stems from the mutually repulsive forces of the negatively- 
charged polysaccharide side-chains, resulting in their 
occupation of the greatest amount of space. This elec¬ 
trostatic interaction by itself contributes to cartilage 
elasticity. This structure also allows it to retain 
large quantities of water, and gives it the ability to 
absorb stresses placed on the cartilage by increasing 
the viscosity of the cartilage matrix (McDevitt 1973)* 
This shock-absorbing quality is unique to cartilage. 
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The proteoglycans are synthesized by the chon¬ 
drocytes. The polypeptide chain Is made on the ribosomes. 
The disaccharides are formed separately and are then 
polymerized at the appropriate linkage sites on the poly¬ 
peptide (Horwitz 2c Dorfman 1968) . Sulphation occurs 
both in the rough endoplasmic reticulum and Golgi appa¬ 
ratus (Martinez, et al 1977)* The molecules are then 
packaged, also in the Golgi apparatur, and released. 
Some form of feedback regulation appears to 
be in operation. Chondrocytes have been shown both in 
vitro (Bosmann 1968) and in vivo (Edwards & Michael 1977) 
to respond to depletion of proteoglycan by increasing 
production. 
Proteoglycans are degraded by both lysosomal 
and non-sysosomal enzymes present in the cartilage 
(Chrisman 2c Fessel 1962, All 1964). Using -^S-SO^, 
Maroudas (1975) was able to measure the half life of 
cartilage. She found that the Ti. of the femoral head 
cartilage was 800 days while that of the femoral cond¬ 
yle cartilage was J00 days. She also found that diff¬ 
erences occurred between different depths of the carti¬ 
lage. Hall, et al (1977)• on the other hand, found that 
although most of the proteoglycan in rabbits had a life¬ 
span of 600 days, 9•5% of it had a half life of only 6.8 
days, implying an active and inactive pool of proteo¬ 
glycans. Turnover of the glycosaminoglycans occurs at 
different rates, with keratan sulphate being turned over 
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faster than the chondroitln sulphates. 
There is variation in the concentration of 
glycosarainoglycans both depending on the depth (Lipshitz, 
et al 1976) and the topographical location (Bjelle 197*0 • 
An increase in concentration with depth occurs, up to 
about 2>5% of the cartilage depth, followed by a gradual 
decline (Lipshitz, et al 197^)* Bjelle (197*+) showed 
significant differences in the hexosamine concentrations 
in different locations of the femoral side of the knee 
joint. There is also considerable variation from one 
person to the next (Maroudas 1975)* 
The negative charges of the sulphate and car- 
boxylate groups combine with many dyes which allow the 
hexosamines to be identified histochemically. Safranin-O, 
for example, can be used to detect the glycosaminogly¬ 
cans semi-quantitatively (Rosenberg 1971)* Under pro¬ 
per conditions, the dye binds stoichiometrically to the 
negatively charged groups. There is no interference from 
the collagen. 
Architecture 
Classically, using techniques of light micro¬ 
scopy, the architecture,of articular cartilage consists 
of the following zones proceeding from superficial to 
deep* the gliding zone, the transitional zone, the radial 
zone, the tidemark and the calcified zone, which lies 
over the subchondral bone. Recent ultrastructural work 
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has increased our knowledge of the histology but the 
names of the basic zones may be largely retained. 
a. The gliding zone: This is subdivided into two 
layers: the superficial and tangential layers. The super¬ 
ficial layer is about 200 microns thick and consists only 
of fine collagen fibrils arranged randomly (Redler 1974). 
There is no proteoglycan in this layer. In the tangen¬ 
tial layer, collagen fibers are arranged in a plane para¬ 
llel to that of joint motion (Redler 1974). Cells in 
this layer resemble fibroblasts with their long axes 
in a tangential plane. It has been found that the su¬ 
perficial layers have a higher tensile strength to forces 
parallel rather than perpendicular, to the direction of 
joint motion (Woo, et al 1976), a finding consistent 
with the ultrastructural observations. This combination 
of fine fibrils with underlying fibers is seen by the 
scanning electron microscope as a series of gently undu¬ 
lating ridges and furrows (Redler 1974). It is proposed 
that this topographical arrangement serves as a means of 
facilitating joint lubrication by allowing collection 
of synovial fluid (Chrlsman 1978) . The tangential 
orientation of the collagen fibers is also ideal for 
resisting destruction due to the shearing forces of joint 
articulation. 
b. The transitional zone: The ratio of cells to 
matrix decreases as the depth increases. The chondro¬ 
cytes tend to be in spherical lacunae, separated by matrix 

containing water, collagen and proteoglycan. Some of 
the collagen bundles are no longer tangential but are 
oblique. 
c. The radial zone: Deep to the transitional 
zone, a zone of more radially oriented collagen fibers 
are encountered. The chondrocytes are seen under the 
light microscope to be lined up in columns. Some of 
the radial bundles form arcade-like patterns (Hunter & 
Finley 1973) although the arches are not formed by con¬ 
tinuous fibers. Deep in the zone, the bundles tend to 
anastomose into large bundles and merge into the calci¬ 
fied zone (Redler, et al 1975)* The radial arrangement 
provides the cartilage with strength against compressional 
stresses, as in joint load-bearing. This zone is also 
particularly rich in proteoglycans and water, which 
gives it the elasticity and added stiffness (Meachim & 
Stockwell 1973) • 
d. The tidemark: This is an undulating, hemat¬ 
oxylin-staining line of 2 to 5 microns in thickness, 
which demarcates the calcified and uncalcified portions 
of articular cartilage. There are 3 bands discernible: 
(1) a band of randomly-oriented fibrils continuous with 
those of each side of the tidemark, (2) a band of fibrils 
larallel to the surface of the calcified cartilage and 
(3) a band of fibrils oriented perpendicular to that 
surface. It has been suggested that this arrangement 
serves as a tethering mechanism for the flexible radial 
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fibers of the radial zone and prevents them from being 
sheared off by tangential stresses at their points of 
anchorage to calcified cartilage (Eedler, et al 1975)* 
e. The calcified zone: Calfification of this zone 
increases with skeletal maturity. In Immature cartilage, 
there are short columns of chondrocytes separated by 
matrix. Vascular structures are present, with calci¬ 
fication most advanced In the perivascular areas. Cal¬ 
cification continues to progress upon skeletal maturity, 
with loss of the columnar organization of the chondro¬ 
cytes. The function of the calcified zone is to provide 
the non-calcifled cartilage with a firm attachment to 
the sub-chondral bone (Meachim & Stockwell 1973). with 
which it has a markedly undulating interface. 
f. The subchondral bone 8 This is not part of the 
articular cartilage per se. There is an endplate con¬ 
sisting of dense cortical bone which supports the carti¬ 
lage. In turn it is supported by trabecular bone. It 





OstoarthrltIs (degenerative joint disease, 
hypertrophic arthritis) is a condition which afflicts 
a large segment of the older population. In young peo¬ 
ple, osteoarthritis may occur as a result of trauma, 
septic arthritis or congenital abnormalities of either 
a biochemical or morphological nature (secondary form). 
The exact etiology and pathogenesis of osteoarthritis, 
especially that which afflicts the older age group 
(primary form), have not been completely worked out. 
However, some of the current ideas will be discussed 
later. There is at present no cure for it. Treatment 
is directed towards minimizing symptoms and incapacit¬ 
ation. 
Clinical Manifestations 
The most important complaint of patients with 
this condition is joint,pain, especially with motion and 
weight bearing. There is also stiffness, but unlike 
rheumatoid arthritis, the pattern of prolonged morning 
stiffness, gradually subsiding, is usually absent. On 
physical examination, there is often decreased range of 
motion, tenderness to palpation with perhaps a small 
effusion, some bone enlargement and crepitus. Markedly 
warm and erythematous joints are unusual. (Mannik & 
Gilliland 1977) • 
When the distal lnterphalangeal joints of the 
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fingers are Involved, bony nodules at the base of the 
distal phalanges (Heberden's nodes) are found, the cor¬ 
responding lesions of the proximal lnterphalangeal joints 
are called Bouchard's nodes. Wrists, elbows and shoulders 
are uncommonly affected. 
Osteoarthritis of the spine usually causes 
back pain and stiffness. Radiologically, osteophytes 
are readily seen although most cases are asymptomatic. 
They may encroach upon the spinal foramina and cause 
nerve root compression giving rise to radicular pain, 
weakness of affected muscle groups and even muscle 
atrophy. In the cervical area, they may occlude the 
vertebral artery on turning the head, giving rise to 
transient visual disturbances or syncope. 
Hip involvement is one of the most disabling. 
With severe Involvement, patients may be completely un¬ 
able to ambulate on their own. Patients complain of 
pain in the hips, groin or knees. Radiologically, there 
is often loss of joint space (indicating articular car¬ 
tilage destruction) and bony thickening of the femoral 
heads. Secondary osteoarthritis of the hip usually 
occurs at an earlier age. The causes include trauma, 
fractures, septic arthritis, rheumatoid arthritis, any 
congenital abnormalities of the hip (dislocation, dys¬ 
plasia), slipped capital femoral epiphysis and avascu¬ 
lar necrosis (often associated with sickle cell disease, 
steroid therapy, etc.). 

15- 
Trauma is usually the cause of osteoarthritis 
of the knee. Injuries to the menisci or supporting 
ligaments give rise to joint instability and abnormal 
wear and tear of the articular cartilage. Pain on weight¬ 
bearing and ambulation is the most common complaint. 
Similarly, involvement of the ankles in osteo¬ 
arthritis is often associated with trauma. Primary os¬ 
teoarthritis of the ankles is uncommon. 
It is of note that polyarticular osteoarthritis 
is a manifestation of acromegaly. There is a thicken¬ 
ing of the synovial membranes and articular cartilage. 
As mentioned before (Chrisman 1975)• growth hormone can 
cause mitosis and DNA production in "dormant" chondro¬ 
cytes . 
Diagnosis 
The diagnosis is suggested by the age, symptoms, 
pattern of joint involvement and lack of accompanying 
abnormalities. 
There is usually no elevation of the erythro¬ 
cyte sedimentation rate. The joint fluid is often slight¬ 
ly turbid and may have a small amount of fibrin clot. The 
white cell count should be less than 2000 per mm^ with 
less than 25% polymorphonuclear cells. Higher white cell 
counts suggest the presence of the more inflammatory arthri- 
tldes (rheumatoid, septic, etc.). 
Radiological examination of the joints is very 
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useful for determining the extent of disease and for 
following its progress. Narrowing of the joint spaces, 
lipping, osteophytes are all consistent with but not 
diagnostic of osteoarthritis. 
Treatment 
Treatment of osteoarthritis is aimed at the 
relief of pain and the minimization of disability. Gen¬ 
eral measures include a weight reduction program for 
over-weight individuals and a program of moderate exer¬ 
cise. A decrease in load-bearing on large joints helps 
decrease symptoms although no significant correlation 
between obesity and osteoarthritis has been found (Sav- 
ille and Dickson 1968) . The exercise program is aimed 
toward maintenance of joint mobility but heavy exercise 
should be avoided as further trauma can occur. The 
patient should be kept reassured that, in the majority 
of cases, osteoarthritis is neither fatal nor crippling 
(Howell, et al 1968) . 
The mainstay of drug therapy is aspirin at 
a dose of 2 to 4 gm. a day, if tolerated by the patient. 
For those who do not tolerate aspirin well, other po¬ 
tent anti-inflammatory and analgesic agents are avail¬ 
able but they have their own problems of adverse effects. 
Indomethacln (75 to 100 mg. a day) is very effective in 
many patients as is phenylbutazone (200 to 400 mg. a 
day) but the latter drug should be used only for short 
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periods (1 week) due to its toxicity and should be reserv 
ed for treatment of acute exacerbations of symptoms. 
Among those patients who do not respond well 
to medical management, a portion will benefit from sur¬ 
gical procedures which include osteotomies, arthroplas¬ 
ties and joint replacements. The hip joint has enjoyed 
the best results in total replacement, using a variety 
of prostheses, the most popular ones being those of 
Charnley (1961) and McKee and Farrar (McKee & Watson- 
Farrar 1966). Follow-up studies have been very impress¬ 
ive, with good to excellent success rates of these two 
methods being greater than 90% on follow-ups of up to 
10 years (Charnley & Cupic 1973. McKee & Chen 1973)* 
This has been considered a major advancement in the man¬ 
agement of osteoarthritis of the hip and has spared many 
patients from pain and disability. 
Pathology 
The earliest pathological changes are chond¬ 
romalacia (loss of proteoglycan from articular cartilage) 
and fissuring. The articular surface becomes slightly 
irregular (Robbins 197^)• With progression of chondro¬ 
malacia, there is an increase in the number of chond¬ 
rocytes which are distributed in clusters (’'cloning") 
(Mankin & Llppielo 1970). In addition, deep clefts or 
fissures form in the cartilage. The above processes are 
denoted by the term "fibrillation", which is considered 

18. 
to be the hallmark of degenerative change In osteo¬ 
arthritis (Collins 1949). Correlating this with the 
present ultrastructural data, one can conclude that as 
the superficial tangential layers lose proteoglycan, 
the layers are destroyed and are denuded. The underlying 
radial fibers are then exposed to the joint stresses 
and are in turn damaged along their lines of weakness, 
giving rise to histological fissuring. Eventually, 
continued wear and tear of the unprotected cartilage 
leads to massive denudation, which shows up radiolo- 
glcally as narrowing of the joint space. 
The exposed underlying bone becomes thicken¬ 
ed with new bone formation. In the marrow of the same 
region, small islands of cartilage of sometimes fibrous 
tissue (pseudocysts), are observed, which may have been 
either "driven in" or formed de novo (Robbins 1974). 
Some cartilage, especially that around the margins, 
ossify and project above the surface to form the charac¬ 
teristic spurs or osteophytes. The denuded surface 
of the bone itself becomes dense, smooth and glistening 
(eburnatlon) (Mannik Sc Gilliland 1976). 
There is some thickening and inflammatory 
edema of the synovia, but this is low grade and does not 
have the vascularization or leukocytic infiltration 





What causes the osteoarthritic changes? This 
question is more easily answered for the secondary 
forms than for the primary form. 
It has long been held that osteoarthritis 
occurs as a consequence of trauma which results in some 
alteration of the joint anatomy. In recent years, with 
our greater awareness of the biochemical make-up of 
tissues, the definition of trauma was naturally broad¬ 
ened to cover any events which cause some microstruc- 
tural or biochemical changes in the joint. Much work 
has been done in the Induction of osteoarthritis by 
applying stresses to the joints under laboratory cond¬ 
itions . 
The role played by mechanical trauma is 
obvious and well-documented. Among the many studies 
available is that Lane, et al (1978) who performed 
medial meniscectomies and transections of the medial 
collateral and both cruciate ligaments of rabbit knees. 
It was found that, although it took 2 months for gross 
histological changes to occur, it took only 1 day for 
detectable changes in the mechanical properties to take 
place. Presumably, osteoarthritis develops as a result 
of abnormal contact pressures. In osteoarthritis as¬ 
sociated with burnt out rheumatoid arthritis, synovial 
and periarticular tissues proliferate and invade the 
articular cartilage (Mills 1970). The inflammatory 
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reaction resulting from a septic joint will induce the 
same changes. 
The intra-articular presence of crystals in 
gout, pseudogout and ochronosis (Laskar & Sargison 1970) 
gives rise to abrasion of the articular surface and in 
addition can trigger off a foreign body reaction in the 
synovium (Sokoloff 1972). 
Structural abnormalities secondary to condi¬ 
tions such as the dysplasias, Perthe's disease, fracture, 
dislocation and infarction fall into the broad category 
of mechanical trauma secondary to joint deformation. 
In short, any event or condition which alters 
the make-up of the joint, be it anatomical, cellular 
or biochemical, will predispose that joint to develop 
osteoarthrltlc changes. 
What about the more common primary or "idio¬ 
pathic" form? Here, very little is known about the 
inciting or etiological event. It is widely, though 
not universally, believed that the first changes occur 
in the articular cartilage. There are those who pro¬ 
pose that vascular changes in the underlying bone are 
the Initial events (Arnold!, e£ al 1972, Brookes & 
Helal 1968, Hulth & Hernborg 1968). Others propose that 
the initial event is the loss of resilience in the 
underlying bony trabeculae (Radin & Paul 1970). With¬ 
out going into the controversies surrounding the diff¬ 
erent hypotheses, it is sufficient to say that most 
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workers a?ree that the Initial events affect the arti¬ 
cular cartilage (fibrillation). This begs the question 
regarding what leads to fibrillation. Putting together 
the fact that osteoarthritis tends to occur in old 
people and that any form of trauma can give rise to 
osteoarthritis, it is attractive to postulate that the 
inciting event in primary osteoarthritis is the damage 
accumulated from small doses of minor trauma during 
long-standing, normal use. Although attractive, this 
hypothesis is difficult, if not impossible, to prove, 
since there are no good laboratory or epidemiological 
models for "normal use". 
One question has been whether osteoarthritlc 
change represents an accelaration of normal ageing in 
articular cartilage. Comparison of autopsy material 
has shown that fibrillation can be found in the joints 
of unselected subjects (Meachim 1972), similar to that 
in osteoarthritic patients, but of a less advanced 
stage. On the other hand, 3yers, et al (1970) looked 
at the location of these lesions and found significant 
differences between osteoarthritic and unselected cases. 
As noted earlier, the composition of the pro¬ 
teoglycans changes with age. Could this be the Initial 
event? Again, there is no data available. 
In summary, the etiology of primary osteo¬ 
arthritis is unknown. The notion of long-standing, 
normal use as being the cause is attractive but difficult 
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to prove scientifically. 
Whatever the etiological factors are, the end 
result is the same. There is a loss of proteoglycans 
accompanied by a deterioration of the mechanical pro¬ 
perties of the cartilage (Lane, et_ al 1978. McDevitt 
1973)* As the process of fibrillation advances, ul¬ 
ceration and erosion can be seen histologically. 
How does this loss of proteoglycan take place? 
The presence of various species of degradative enzymes 
have been demonstrated in the synovial fluid (Lack & 
Ali 1967» Sapolsky, et_ aJL 1973# 197^. Ehrlich, et_ al 
1975)» the best known of which were the cathepsins, 
also found in rheumatoid synovia. However, it was later 
discovered that purified cathepsins have little proteo¬ 
lytic activity as the pH increases to 7 and that the 
significant tail-end of its activity at that pH was 
actually due to a contaminant in the previous cathepsin 
preparations (Woessner 1973. 1973a). By using known 
inhibitors of the cathepsins and various other enzymes 
of the synovia and leukocytes, Howell demonstrated that, 
at the pH of synovial fluid, proteolytic activity re¬ 
sided in a neutral protease derived from the chondro¬ 
cytes (Howell 1975)* This protease was inhibited by 
chloroquine. Teitz and Chrisman ( 1975) found that 
chloroquine inhibited the prostaglandin-induced destruc¬ 
tion of rabbit articular cartilage. These authors felt 
that the action of chloroquine might be to inhibit the 
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synthesis of proteases. In light of the findings of 
other workers (Sapolsky, et al 197*0. the action may 
be direct inhibition of the neutral protease. This 
distinction between the cathepsins and the neutral 
proteases may be regarded as merely a semantic one. 
The actions of the enzymes are similar, they merely have 
their activities at different pH ranges. Therefore the 
cathepsins can be regarded as acid proteases and con¬ 
versely, the neutral protease can be regarded as a 
neutral or basic cathepsin. 
With the identity of the protease established, 
we need to ask why it is present. There is no clear 
answer to that question. It has been proposed that the 
protease forms part of a system of continuous turnover 
of cartilage proteoglycan (Howell 1975)* As sugested 
by George & Chrisman (1968), joint motion may give rise 
to matrix and cellular debris abraded from the surfaces 
and some mechanism is needed for removing it. The ac¬ 
tion of the protease could easily fit into such a scheme. 
Osteoarthritis may then represent a process where, for 
some, reason, the protease becomes overactive, or that 
the proteoglycan-synthesizing capabilities of the chond¬ 
rocytes become underactive, or some combination of both 
of the above. 
We now need to consider what factors trigger 
off the proteolytic action mentioned above. Much work 
has been done in this area and the leading candidates 
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seem to be either the cyclic nucleotides or the prosta¬ 
glandins. As will be discussed below, these 2 classes 
of compounds interact very closely and may turn out to 
be different components mediating the same sequence of 
events. 
It is well-known that cholera endotoxin stim¬ 
ulates the production of cyclic adenosine monophosphate 
(cAMF). Prostaglandins also seem to have this property. 
Application of either cholera endotoxin or prostaglandin 
(PGE^) to ileal mucosa causes inhibition of sodium 
absorption and stimulation of chloride secretion (Green- 
ough, et, al 1969. Al-Awqati, et al 1970). 
Using the _in vitro system to be described 
below, Fulkerson, et al (1978) showed that cholera en¬ 
dotoxin caused loss of proteoglycan from dog articular 
cartilage. In an analogous in vivo experiment, Floman, 
et al (1977) injected cell-free extracts of streptococci 
into rat knee joints and found a 3-fold rise in cathep- 
sin D in the synovium. It has been suggested that en¬ 
dotoxins stimulate CAMP via a prostaglandin Intermediate 
(Bennett 1971. Jacoby 8c Marshall 1972, Floman, et al 
1977. Herman 8c Moncada 1975)* In some of these experi¬ 
ments (Jacoby & Marshall 1972, Floman, et al 1977, 
Herman & Moncada 1975). a rise in prostaglandins could 
be measured, which could be prevented by addition of 
prostaglandin synthetase inhibitors such as lndomethacin. 
This inhibition was accompanied by an inhibition of the 
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effects of endotoxins. 
It should be noted, however, that this effect 
has not been universally demonstrated. Prostaglandin 
synthetase inhibitors failed to prevent endotoxin- 
induced lipolysls in Isolated fat cells (Cuatrecasas 
1973) or cAMP accumulation in human leukocytes (Bourne 
1973)* It is possible that endotoxins can directly 
stimulate cAMP production without going through pros¬ 
taglandins . 
A further complication is added by the work 
of Kuehl (197*** Kuehl, et al 197*0* who showed, that, 
in some systems, there exists a post-cAMP pool of pros¬ 
taglandins. This pool would be intra-cellular and would 
not be expected to respond to the action of prostaglan¬ 
din synthetase inhibitors. Thus, he proposed a more 
complex modulating role of the prostaglandins rather 
than a straightforward stimulating role. 
Despite the controversies surrounding the 
inter-relationship between the prostaglandins and cAMP, 
we may propose a tentative model for the pathogenesis 
of osteoarthritis (Figure 2). Any form of trauma 
results in some alteration of physical forces in the 
joint which, by some yet unknown mechanism, causes an 
increase in prostaglandins in the joint. In the case 
of the primary form of osteoarthritis, the pathogenetic 
sequence is assumed to begin here. The prostaglandins 
then stimulate cAMP, cause a release of proteases, 
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which then degrade cartilage proteoglycans and give 
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Previous work performed in this laboratory 
has demonstrated that prostaglandins can induce damage 
to rabbit knees, as shown by histological examination 
(Teitz & Chrlsman 1975)* Since then, an _in vitro 
system has been developed in this laboratory whereby 
the actual loss of proteoglycan from the articular 
cartilage can be biochemically determined. 
Briefly, the overall experimental method 
is as follows: Fresh articular cartilage is excised 
from dogs* knees and placed in a series of solutions 
containing the appropriate agents to be tested (pros¬ 
taglandins, endotoxin, etc.). The cartilage slices 
are then recovered and the concentration of proteogly¬ 
cans remaining are assayed by the method of Rondle and 
Morgan (1955)* By this method, the cartilage is hydro¬ 
lyzed with concentrated hydrochloric acid. This breaks 
down the proteoglycan into hexosamines, the concentra¬ 
tion of which can be determined spectrophotometrically. 
Using this method, the prostaglandin-induced 
degradation of articular cartilage and the protective 
action of chloroquine has been demonstrated (Fulkerson, 
et al 1978). In addition, the system has also been 
employed to show the degradation of articular cartilage 
by cholera endotoxin (Fulkerson, et al 1978a). 
The present study aims at demonstrating the 
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effects of arachidonic acid on articular cartilage. 
It has been shown that chondrocytes in cell culture 
are able to synthesize prostaglandins from arachidonic 
acid (Lippiello, et al 1977). If this is so, then 
introduction of arachidonic acid into the incubation 
medium of the cartilage slices should result in pros¬ 
taglandin production and cartilage degradation. This 
would provide an in vitro mbdel for part of the patho¬ 
genesis of osteoarthritis. 
Furthermore, this would provide a useful 
system for the evaluation of the potency of prostaglan¬ 
din synthetase inhibitors. Many such agents are used 
in the treatment of osteoarthritis. Indomethacin 
(Figure 3) is one of them and its clinical and pharma¬ 
cological properties have been well described (Woodbury 
& Fingl 1975) • 
Sulindac is a new non-steroidal anti-inflam¬ 
matory agent which has recently been released by the 
Food and Drug Admlnistration for the treatment of ar¬ 
thritis. It is a congener of indomethacin and is claimed 
to have fewer side effects (BianchiPorro, et. al 1977» 
Lancet 1977)* It has been speculated that the reason 
for the lower incidence of side-effects (mostly gas¬ 
trointestinal) is related to its unique metabolism 
(Duggan, et al 1977)• Sulindac, which is a sulfoxide, 
is metabolized by the liver to the sulfone and sulfide 




Figure 3* The chemical structure of indomethacin. 
(sulfide) sulindac (sulfone) 
(sulfoxide) 
COOH 
Figure 4i The chemical structures of sulindac and its 
sulfide and sulfone metabolites. 
(From Duggan, et al 1977) 
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in the urine and has no pharmacological actions. The 
sulfide is not excreted in the urine (Shen 1976). It 
is many times more active than sulindac itself in its 
anti-inflammatory action in several in vivo models of 
inflammation (Duggan, et al 1977)* Thus, it can be 
considered a "pro drug" with little action until meta¬ 
bolized by the liver and this may help explain the lower 
incidence of gastrointestinal side effects. 
In the present work, the ability of the 
chondrocytes to synthesize prostaglandins from arachi- 
donic acid will be shown by incubating cartilage slices 
in medium containing arachidonic acid and observing the 
loss of hexosamine from the cartilage. In addition, 
indomethacin and sulindac will be used to show that 
inhibition of prostaglandin synthesis will result in 




Preparation of solutions 
1. Incubation solutions! Solutions were 
prepared immediately before use. Indoraethacin* and the 
sulfide metabolite of sulindac** were dissolved in 
sterile lactated Ringer’s solution in appropriate con¬ 
centrations. Arachidonic acid*** was dissolved in 
absolute ethanol. Various quantities of each reagent 
and solvent were transferred into sterile 50*®1» Erlen- 
mayer flasks stoppered with cotton wool plugs, such 
that the total volume of solution was always 6 ml. 
2. Alkaline acetylacetonet Two ml. of 
acetylacetone (Fisher Scientific Co.) were dissolved 
in 0.5 N Na2C0^ to make 50 ml. of solution, and used 
not more than 2 hours after preparation. 
3* Ehrlich's reagent! 0.8 gm. of £-dimethyl- 
aminobenzaldehyde (Fisher Scientific Co.) was dissolved 
in 30 ml. of absolute ethanol. To this was added 30 
ml. of concentrated hydrochloric acid. The reagent was 
used within 2 hours. 
* Binder-free indomethacin (L-590,226-00A116) was 
kindly supplied by F. A* Cutler, Ph.D. of Merck, 
Sharp and Dohne Laboratories, F. 0. Box 2000, 
Rahway, New Jersey 07065* 
** 3inder-free sulfide metabolite of sulindac 
(L-612,835“°OX25) was kindly supplied by Merck, 
Sharp and Dohne Laboratories, above address. 
*** Na arachidonate from Sigma Chemicals, St. Louis, 
Missouri 63178. Lot no. 18C-7580. 
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4. Glucosamine standard solutions: Fourteen 
mg. of glucosamine EC1 (Sigma Chemical Co.) were dis¬ 
solved in 100 ml. of distilled water and kept refrigerated 
until used (less than a week). 
Procedure 
Fresh articular cartilage was obtained from 
adult dogs killed by intracardiac administration of 
pentobarbital immediately before surgery. The knees 
were shaved and prepped with Betadine scrub and alcohol 
and sterile technique was observed during the procedure. 
Each knee joint was exposed employing an anteriorly 
located vertical skin incision passing just medial to 
the patella. The joint was then entered with a hori¬ 
zontal incision through the anterior portion of the 
capsule, transecting both the medial and lateral colla- 
o 
teral ligaments. Finally, the cruciate ligaments were 
transected and the menisci were removed to expose the 
articular surfaces. A fresh scalpel blade (#10) was 
then used to shave off pieces of articular cartilage. 
Most of the cartilage used in the experiments came from 
the femoral surfaces, with additional amounts from the 
tlblal and patellar surfaces. Most slices measured 
2-3 mm. X 5 mm. and were of full thickness. The slices 
were immediately Introduced into the Incubating solutions 
after pooling them in a Petri dish. 
The flasks were incubated in an Sberbach 
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shaker bath at 37°C ± 1 for 24 hours with moderate sha¬ 
king (60 - 90 strokes per minute). At the end of this 
period, each flask was Inspected for cloudiness suggestive 
of bacterial contamination. Suspicious solutions were 
sent for bacterial culture and, if positive, were dis¬ 
carded. Each sample was defatted and partly dehydrated 
by placing in 2 ml. of a 1:1 mixture of acetone and ethanol 
for 24 hours. The cartilage slices were recovered and 
the solvent completely driven off by placing in an evac¬ 
uated oven at 60°C overnight. Two to 3 mg« of the dry 
cartilage was then weighed for the hexosamine assay. 
The method for liberating the glucosamine was 
derived from the work of Boas (1953)* Previous work done 
in this laboratory had shown that the best results were 
obtained (in terms of complete hydrolysis with minimal 
decomposition) by incubating the cartilage in 2 ml. of 
4.25 N hydrochloric acid in 10-ml. volumetric flasks 
for 4 hours. At the end of this period, the solutions 
were topped to the 10-ml. mark with distilled water and 
filtered by gravity through Whatman no. 1 paper into a 
second set of 10ml. volumetric flasks. 
At this point, blanks were prepared by pipet¬ 
ting into 10-ml. volumetric flasks 2 ml. of the same 
4.25 N hydrochloric acid used in the hydrolysis and then 
topping to the mark. The standards were prepared by 
pipetting 0.5, 1.0, 1.5 and 2.0 ml. of the glucosamine 
HG1 standard solution into 10-ml. volumetric flasks, add- 
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ing 2 ml. of 4.25 N hydrochloric acid and then topping to 
the mark with distilled water. The blanks and standards, 
however, were not filtered. From this point on, samples, 
blanks and standards were treated in an identical fash¬ 
ion. 
The method employed for the quantitative deter¬ 
mination of glucosamine was described by Rondle and 
Morgan (1955)# which was a modification of the original 
method of Slson and Morgan (1933)* 
A 3-mi* aliquot from each flask was pipetted 
into a 10-ml. volumetric flask, titrated to the phe- 
nolphthalein end-point with 4 N NaOH and then back- 
titrated with 0.5 N HC1 until the pink returned to co¬ 
lorless. Extreme care was necessary in this step since 
the assay is sensitive to both salt concentration and 
pH (3oas 1953). Next, 1 ml. of alkaline acetylacetone 
was added to each flask and heated in a boiling water 
bath for 30 minutes. The flasks were allowed to cool 
to room temperature. About 2 ml. of absolute ethanol 
were added, followed by 1.0 ml. of Ehrlich’s reagent, 
in turn followed by sufficient ethanol to fill to the 
10-ml. mark. The flasks were warmed to 65 - 70°G in 
a water bath for 15 minutes. 
A Varian Series 634 spectrophotometer was 
used to read the absorbance at 530 nm. at a slit width 
of 1 nm. and a path length fo 1 cm. All standards and 
samples were read at least twice against a blank refer- 
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ence and the average reading was used. 
The standard curve was obtained using a lin¬ 
ear least squares plot. 
On most runs, the elapsed time between the 
addition of acetylacetone and the spectrophotometric 
determination was less than 6 hours. Similarly, the 
elapsed time between the addition of Ehrlich's reagent 
and final determination was less than 3 hours. 
The data obtained was analyzed statistically 




The results of the experiments are represented 
In Tables 1 through 3* -All values obtained are expressed 
in arbitrary units to facilitate comparison between 
different experiments. This is because, with the part¬ 
icular assay method employed, differences occur in the 
absolute values obtained from one experiment to the 
next, although they are internally cons within each 
experiment (Rondle & Morgan 1955)» 
Table 1 shows the effect of arachidonic acid 
on the hexosamine content. When the concentration 
of the arachidonic acid in the incubating medium was 
1 mcg/ml., no difference in the hexosamine content was 
noted between that and the controls. When the concen¬ 
tration of the arachidonic acid was increased to 10 
mcg/ml., there was a significant (?<0.01) drop in the 
hexosamine content from 100 to 72.6 arbitrary units. 
Further increasing the concentration of arachidonic 
acid to 100 mcg/ml. resulted in no change in the loss 
of hexosamine. 
The effects of indomethacin on the system are 
shown in Table 2. The control values are set arbi¬ 
trarily to 100. As expected, the presence of 10 mcg/ml. 
of arachidonic acid caused a drop in the hexosamine 
content, although the statistical significance of the 
results is not as good (P<0.10 for Dog A, results insig¬ 
nificant for Dog B) . Indomethacin alone did not cause 
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a change in the concentration, showing that It has no 
effect per se on the cartilage. The results of having 
both the indomethacin and arachidonlc acid in the medium 
is slightly confusing. In the case of Dog A, the value 
obtained is half-way between that of the control value 
and that obtained with arachidonic acid alone. For Dog 
B, the value indicates a fully protective effect from 
the indomethacin. Since the sample size in the case 
of Dog A is small (n=3), one might expect it to be more 
easily influenced by random errors and would be less 
reliable. The sample size in the case of Dog B is 
bigger (n=6) and one would expect greater significance 
in the result. At any rate, Dog A still shows some 
protective effect rendered by the Indomethacin. 
In Table 3. the results of similar experiments, 
but using the sulfide metabolite of sullndac, are shown. 
Again, arachidonic acid causes loss of hexosamine. The 
values for Dog C are statistically insignifleant while 
those for Dog D are (P<0.05)« The sulfide metabolite 
of sullndac by itself causes no change in the hexos¬ 
amine content. With both arachidonic acid and the sul¬ 
fide metabolite of sullndac together, no change is noted 
in the hexosamine content, demonstrating the protective 
effects of the sulfide metabolite of sullndac, which 
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The foregoing experiments serve to demonstrate 
the effect of arachidonic acid on cartilage degradation. 
In all cases a drop in the amount of hexosamine is noted 
in samples containing the arachidonic acid (but without 
the prostaglandin synthetase inhibitors) as compared to 
controls which contained only lactated Ringer's solution 
and alcohol or which contained indomethacin or sulindac. 
Only low concentrations of arachidonic acid are necess¬ 
ary, as shown by the observation that increasing the 
concentration from 10 mcg/ml. to 100 mcg/ml. caused no 
further increase in hexosamine loss. 
Furthermore, this not a direct effect of 
the arachidonic acid itself since if that were true, 
the indomethacin should not prevent the loss of hexo¬ 
samine induced by the arachidonic acid. One might argue, 
on the other hand, that there may be a direct inter¬ 
action between the indomethacin and arachidonic acid. 
The results are consistent with such a hypothesis as 
well. However, there is little evidence in the literature 
to support such a statement and there is much work to 
support the hypothesis that the action of indomethacin 
is by inhibition of prostaglandin synthesis (Vane 1971, 
Ferreira & Vane 197^» etc.). 
Since chondrocytes are the only cells present 
in this system, they must be the source of prostaglandin 
synthetase. This agrees well with the previously- 
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mentioned work of Lippiello, et al (1977) who demonstrat¬ 
ed that chondrocytes in cell culture were capable of 
prostaglandin synthesis. This system, moreover, has 
the chondrocytes in a milieu which much better approx¬ 
imates the in vivo conditions. 
Another advantage of this system is that there 
is no interference from the enzyme systems from the 
much more cellular synovium. None of the work performed 
on _in vivo systems can resolve the question as to whe¬ 
ther the prostaglandins came from the synovial or cart¬ 
ilage cell synthesizing systems. This experiment shows 
that the latter are capable of producing the prosta¬ 
glandins, although the question as to whether these 
prostaglandins or those originating from the synovium 
are ultimately more important in cartilage degradation. 
Certainly, in conditions such as rheumatoid or septic 
arthritis, intense synovitis is seen and the large 
amounts of prostaglandins detected in the joint fluid 
probably originate from there. However, the earliest 
osteoarthritic changes are detected in the articular 
cartilage and not in the synovium and it seems reason¬ 
able to conclude that, at least in the early stages, 
the prostaglandins are derived from the chondrocytes. 
Although, in the experiments involving indo- 
methacln and sulindac, the results are not as statis¬ 
tically significant, the trends shown by the results 
are quite clear. In all cases, the effect of the arach- 
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idonic acid In causing the loss of hexosaraine from the 
articular cartilage cannot be demonstrated in the pre¬ 
sence of either indomethacin or the sulfide metabolite 
of sulindac. The only exception is perhaps the case of 
Dog A, where the value for hexosamine loss with both 
Indomethacin and arachidonic acid present fell roughly 
half-way between the values obtained for the controls 
and for arachidonic acid alone. However, the problem 
of the small sample size in that particular case has 
been discussed in the foregoing section. 
The results are thus consistent with the model 
proposed above that the pathogenesis of osteoarthritis 
occurs via a pathway of endogenously-produced prosta¬ 
glandins, leading to the synthesis or activation of 
proteases in the articular cartilage. It also shows 
that sulindac, a recently released non-steroidal anti¬ 
inflammatory agent and a chemical congener of indome¬ 
thacin, also works by inhibition of prostaglandin 
synthesis. 
One question which this experimental system 
is unable to address is the identity of specific pro¬ 
staglandins synthesized. There are at least 6 products 
which may be formed from prostaglandin endoperoxide, 
•5* FGE'S> PGF2K- PGD, PGI, thromboxane. In rheuma¬ 
toid synovial tissue in culture, the main product appears 
to be PGS2, with some PGF2^ and PGB (Robinson 8c Levine 
' 
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1974). Also, It Is well known that different prostag¬ 
landins can have very different and even opposing actions 
(Vane 1971)* Of note is the difference in actions be¬ 
tween PGS2 and PGF2X* In rat knees following the injec¬ 
tion of cell-free extracts of Group A Streptococci, a 
rise in PGS2 was noted within an hour while a rise in 
PGF2<* was noted only after 6 hours (Floman, et al 1977)* 
Fulkerson, et al (1978a) used PGS-]_ and PGS2 in the pre¬ 
sent system and obtained cartilage degradation in both 
cases. Some have proposed that PGE2 is an inflammatory 
prostaglandin while PGF2^_ is an anti-inflammatory one 
(Willoughby & Dieppe 1978). Other workers, on the other 
hand, have postulated a pro-inflammatory action for 
PGF2<x (Weissmann, et al 1978). It would be useful as 
a next step to actually identify which of the prostag¬ 
landins are released during incubation with arachidonic 
acid and this would give Important information on the 
more specific pathway of inflammation. From that point 
on, more specific prostaglandin synthetase inhibitors 
may be found which may have therapeutic advantages. For 
example, the gastrointestinal side-effects of indome- 
thacin have been attributed to depletion of PGSi and 
PGE2 in the gastrointestinal mucosa (Vane 1971* Robert 
197^) which results in a breakdown of the mucus barrier. 
If it turns out that prostaglandins other than PGE-j_ or 
PGE2 are responsible for the osteoarthrltic changes and 
specific inhibitors of these other prostaglandins can be 
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found, then the gastro-intestinal side effects of the 
present agents can be avoided. 
Another point which should be considered in 
the light of these experiments is the actual effect 
of the non-steroidal anti-inflammatory agents in clin¬ 
ical use. Since the agents inhibited the degradation 
of proteoglycans, one could argue that, in clinical 
use, it should retard the progression of osteoarthri¬ 
tis, in addition to providing symptomatic relief. 
There is, however, no data available as to whether 
the non-steroidal anti-inflammatory agents actually 
alter the course of the disease. This is understand¬ 
able since the clinical course of osteoarthritis varies 
tremendously and such long term follow-up studies would 
be virtually impossible to undertake. 
As to the symptomatic relief of osteoarthr¬ 
itis, previous work has shown that FGT-j_ or PGE2 sensi¬ 
tized dogs to intra-articular injection of bradykinin 
(Moncada, et al 1975)* The authors monitored blood 
pressure as a measure of pain and showed that aspirin 
or indomethacin prevented the effects of bradykinin 
but not those of the prostaglandins. Thus, they con¬ 
cluded that local prostaglandin synthesis sensitizes 
pain receptors to noxious stimuli. It has also been 
shown that incapacitation in dogs after intra-articu¬ 
lar injection of endotoxin was highly correlated with 
the prostaglandin level in the synovial fluid (Kerman 
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& Moncada 1975) • Thus, prostaglandins mediate the symp¬ 
toms of pain and incapacitation in the disease. It 
would seem reasonable to conclude that the prostaglan¬ 
din synthetase inhibitors provide symptomatic relief 
by interfering in this pathway. There is no data at 
present to show whether they have any effect of arti¬ 
cular cartilage preservation in osteoarthritis, but 
work on an analogous system has demonstrated such an 
effect. A study conducted on lateral dislocations of 
the patella may shed some light on this question (Chris- 
man, et al 1972, Chrisman & Snook, 1968). Patients were 
treated with a course of aspirin after being seen for 
the first episode of lateral dislocation of the patella. 
When dislocation recurred, surgical correction was rec¬ 
ommended and the amount of chondromalacia judged by the 
system of Bentley (1970) when surgery was performed. 
In the untreated group, 21 out of 23 patients showed 
evidence of chondromalacia of any degree while this was 
true of only 3 of 16 knees in the aspirin-treated group. 
Since chondromalacia is an early finding in osteoarthri¬ 
tis, we have here an analogous situation which shows 
that aspirin in fact helps retard cartilage degradation 
in a clinical setting. 
Possible sources of experimental error 
Some of the values obtained in these experi¬ 
ments showed the trend quite clearly but the actual 
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numbers were not always statistically significant. It 
would seem appropriate to discuss some of the possible 
sources of error in the experimental system. 
In the first place, there is some variation 
in the proteoglycan from animal to animal•(Maroudas 
1975)* The absolute amount of hexosamine cannot be 
meaningfully compared between animals and therefore 
arbitrary units have been employed. However, for each 
given animal, the results should be internally consist¬ 
ent. This is not possible due to a second variation, 
which is the variation in proteoglycan content as a 
function of depth (Lipshitz, et al 1976) and topo¬ 
graphical location in the joint, as discussed before. 
Since the quantity of articular cartilage in each joint 
is extremely limited and all the cartilage which could 
be obtained had to be used, there was little which 
could be done to control for these two variables except 
by cutting the cartilage into very small slices, pool¬ 
ing the cartilage and randomizing the order by which 
the incubation flasks were filled. 
The next step where a source of error is likely 
is the weighing of the dry cartilage. Most samples 
were between 2 and 3 mg. Since the balance reads to 
0.1 mg., the accuracy of the weight is at best +0.1 
mg., which when compared to the sample weight of 2 mg., 
is an error of at least 5 ,£• A larger sample size 
would lower this error but would give rise to the pro- 
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blem of Incomplete hydrolysis. 
It has been shown that hydrolysis of 0.5 mg. 
of purified chondroitln-6-sulphate with 1 ml. of 4 N 
hydrochloric acid under vaccuum at 110°C was complete 
at 4 hours and shows a yield of greater than 90^ at 
the end of 12 hours (Johnson, _et al 1978). The problem 
we encountered was one of incomplete hydrolysis. After 
4 hours, small flecks of black material were noted in 
the hydrolysiate, which increased with the amount of 
cartilage used. The chemical nature of these flecks 
is unknown and therefore, the possibility of their 
containing an unknown amount of hexosamine cannot be 
ruled out. The error introduced in this step is in¬ 
determinate. Carrying on the hydrolysis for a longer 
period might circumvent this problem but we then run 
into the possibility of decomposition of the hexosamine. 
Finally, Boas (1953) pointed out that many 
naturally-occurring substances contained chromogens 
other than hexosamines which would react to the rea¬ 
gents used to produce substances which absorbed at 
530 nm. but with a different spectrum. Using a Dowex 
50 quantitative ion exchange column, he was able to 
purify the hexosamines. However, such a procedure was 
not practical in this case because of the large numbers 
of samples used and the small volume in each sample. 
The error introduced here is again indeterminate. It 
can only be assumed that it was roughly the same in 
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each case and the relative values, which were the im¬ 
portant ones in this experiment, were unaffected. 
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Summary and Conclusions 
Previous work has demonstrated that prosta¬ 
glandins can cause destruction of articular cartilage 
and that this may be part of the pathogenetic pathway 
of osteoarthritis. This paper seeks to elucidate this 
pathway by demonstrating the effect of arachidonlc acid 
on articular cartilage. We shall then attempt to de¬ 
monstrate that such an action can be Inhibited by indo- 
methacln and sulindac. The latter is a new non-steroidal 
anti-inflammatory agent and we shall show that its action 
is similar to that of indomethacin. 
The results show that arachidonlc acid caused 
a significant loss of hexosamines from articular cart¬ 
ilage. The trends of the results show that this effect 
can be inhibited by indomethacin or sulindac, which do 
so most likely by inhibition of prostaglandin synthesis. 
Some of the possible sources of error in the 
experimental system which may have contributed to the 
lack of statistical significance in some of the numbers 
are discussed. Repeating the experiments using larger 
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